【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Peritoneal Cancer Overview 11
Therapeutics Development 12
Pipeline Products for Peritoneal Cancer – Overview 12
Pipeline Products for Peritoneal Cancer – Comparative Analysis 13
Peritoneal Cancer – Therapeutics under Development by Companies 14
Peritoneal Cancer – Therapeutics under Investigation by Universities/Institutes 19
Peritoneal Cancer – Pipeline Products Glance 20
Late Stage Products 20
Clinical Stage Products 21
Early Stage Products 22
Peritoneal Cancer – Products under Development by Companies 23
Peritoneal Cancer – Products under Investigation by Universities/Institutes 28
Peritoneal Cancer – Companies Involved in Therapeutics Development 29
AbbVie Inc. 29
Acceleron Pharma, Inc. 30
Adaptimmune Limited 31
Advanced Accelerator Applications SA 32
Amgen Inc. 33
Astellas Pharma Inc. 34
Astex Pharmaceuticals, Inc. 35
AstraZeneca PLC 36
Basilea Pharmaceutica AG 37
Bayer AG 38
BioMarin Pharmaceutical Inc. 39
Bionomics Limited 40
Boehringer Ingelheim GmbH 41
Celldex Therapeutics, Inc. 42
Celsion Corporation 43
Cerulean Pharma, Inc. 44
Clovis Oncology, Inc. 45
Corcept Therapeutics Incorporated 46
CritiTech, Inc. 47
CTI BioPharma Corp. 48
Eli Lilly and Company 49
Exelixis, Inc. 50
F. Hoffmann-La Roche Ltd. 51
Galena Biopharma, Inc. 52
Genelux Corporation 53
Genentech, Inc. 54
GlaxoSmithKline plc 55
Glycotope GmbH 56
Hemispherx Biopharma, Inc. 57
ImmunoGen, Inc. 58
Immunotope, Inc. 59
Immunovaccine, Inc. 60
Johnson & Johnson 61
Lee’s Pharmaceutical Holdings Limited 62
MabVax Therapeutics Holdings, Inc. 63
MedImmune, LLC 64
Merck & Co., Inc. 65
Merrimack Pharmaceuticals, Inc. 66
NeoStem, Inc. 67
Novartis AG 68
Neovii Biotech GmbH 69
Oasmia Pharmaceutical AB 70
OBI Pharma, Inc. 71
Oncolytics Biotech Inc. 72
OncoMed Pharmaceuticals, Inc. 73
Onxeo SA 74
Oxford BioMedica plc 75
OXiGENE, Inc. 76
Pharma Mar, S.A. 77
Pharmacyclics, Inc. 78
PsiOxus Therapeutics, Ltd. 79
Recepta Biopharma S.A. 80
Sanofi Pasteur SA 81
Synta Pharmaceuticals Corp. 82
Takeda Oncology 83
TapImmune Inc. 84
TetraLogic Pharmaceuticals 85
TRACON Pharmaceuticals, Inc. 86
VentiRx Pharmaceuticals, Inc. 87
Peritoneal Cancer – Therapeutics Assessment 88
Assessment by Monotherapy Products 88
Assessment by Target 89
Assessment by Mechanism of Action 94
Assessment by Route of Administration 98
Assessment by Molecule Type 100
Drug Profiles 102
²¹²Pb-TCMC-Trastuzumab – Drug Profile 102
abexinostat hydrochloride – Drug Profile 104
abiraterone acetate – Drug Profile 106
ABT-767 – Drug Profile 109
alisertib – Drug Profile 110
anetumab ravtansine – Drug Profile 114
AZD-1775 – Drug Profile 116
AZD-2014 – Drug Profile 118
AZD-5363 – Drug Profile 120
BAL-101553 – Drug Profile 122
belinostat – Drug Profile 123
bevacizumab – Drug Profile 126
binimetinib – Drug Profile 131
birinapant – Drug Profile 135
BNC-105P – Drug Profile 138
cabozantinib s-malate – Drug Profile 140
Cancer Stem Cell Therapy – Drug Profile 143
catumaxomab – Drug Profile 144
CDX-1401 – Drug Profile 146
Cell Therapy to Target NY-ESO-1 and LAGE-1 for Oncology – Drug Profile 148
Cell Therapy to Target WT1 for Cancer – Drug Profile 150
CRLX-101 – Drug Profile 151
dalantercept – Drug Profile 153
demcizumab – Drug Profile 155
Dendritic Cell Therapy for Cancer – Drug Profile 159
Dendritic Cell Therapy for Ovarian, Peritoneal and Fallopian Tube Cancer – Drug Profile 160
DMUC-4064A – Drug Profile 161
DPX-Survivac – Drug Profile 162
EGEN-001 – Drug Profile 165
elesclomol – Drug Profile 167
enadenotucirev – Drug Profile 169
erismodegib – Drug Profile 171
fosbretabulin tromethamine – Drug Profile 174
GALE-301 – Drug Profile 178
ganetespib – Drug Profile 180
gimatecan – Drug Profile 184
GLONC-1 – Drug Profile 186
guadecitabine – Drug Profile 189
IMGN-853 – Drug Profile 192
IMT-1012 – Drug Profile 193
ipafricept – Drug Profile 194
LCL-161 – Drug Profile 195
lifastuzumab vedotin – Drug Profile 197
linsitinib – Drug Profile 199
LY-2606368 – Drug Profile 201
MesoCART – Drug Profile 202
mifepristone – Drug Profile 203
MK-2206 – Drug Profile 205
Monoclonal Antibody Conjugate to Target B7-H3 for Cancer – Drug Profile 208
motolimod – Drug Profile 209
MV-NIS – Drug Profile 211
nintedanib – Drug Profile 213
NSC-748933 – Drug Profile 217
OBI-822/821 – Drug Profile 218
olaratumab – Drug Profile 220
paclitaxel – Drug Profile 222
paclitaxel – Drug Profile 224
paclitaxel poliglumex – Drug Profile 225
PankoMab-GEX – Drug Profile 229
pazopanib hydrochloride – Drug Profile 230
pelareorep – Drug Profile 235
ralimetinib mesylate – Drug Profile 240
ramucirumab – Drug Profile 241
RebmAb-100 – Drug Profile 246
regorafenib – Drug Profile 248
rintatolimod – Drug Profile 251
rucaparib phosphate – Drug Profile 252
selumetinib sulfate – Drug Profile 255
seribantumab – Drug Profile 258
SG-2000 – Drug Profile 260
sofituzumab vedotin – Drug Profile 262
sorafenib tosylate – Drug Profile 263
talazoparib – Drug Profile 267
Theranean – Drug Profile 269
TPIV-200 – Drug Profile 270
trabectedin – Drug Profile 272
TRC-105 – Drug Profile 275
trebananib – Drug Profile 277
TroVax – Drug Profile 280
Vaccine for Oncology – Drug Profile 283
Vaccine to Target Carcinoembryonic Antigen for Oncology – Drug Profile 284
vCP-2292 – Drug Profile 285
X-82 – Drug Profile 286
Peritoneal Cancer – Recent Pipeline Updates 287
Peritoneal Cancer – Dormant Projects 428
Peritoneal Cancer – Discontinued Products 429
Peritoneal Cancer – Product Development Milestones 430
Featured News & Press Releases 430
Appendix 433
Methodology 433
Coverage 433
Secondary Research 433
Primary Research 433
Expert Panel Validation 433
Contact Us 434
Disclaimer 434
【レポート販売概要】
■ タイトル：腹膜がん(Peritoneal Cancer)の治療薬パイプライン動向（2015年上半期版）■ 英文：Peritoneal Cancer - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6120IDB
■ 調査対象地域：グローバル
- トリコモナス腟炎(Trichomonas Vaginitis)：世界の治験レビュー2014年下半期版Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014" provides data on the Trichomonas Vaginitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trichomonas Vaginitis. It includes an overview of the trial numbers and the …
- Petoro AS：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Petoro AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Petoro AS Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational dat …
- 麻酔ガス用マスクの世界市場2019-2023Global Anesthetic Gas Masks Market: About this market Technavio’s anesthetic gas masks market analysis considers sales from both disposable and reusable anesthetic gas mask. Our analysis also considers the sales of anesthetic gas masks in Asia, Europe, North America, and ROW. In 2018, the disposable anesthetic gas masks segment had a significant market share, and this trend is expected to continue …
- マルチクッカーの世界市場2015-2019Technavio’s market research analyst predicts the global multicooker market to reach a market value of over $743 million by the end of 2019. The key regions where multicooker adoption is the highest are North America and Europe. Consumers who preferred to eat in restaurants and food outlets, have developed a passion for cooking at home. This trend towards creating restaurant like food at home is pr …
- ベビーカーの世界市場2016-2020Faced with fast-paced modern lifestyles along with the emergence of nuclear and single-parent families worldwide, consumers are increasingly seeking for convenience and safety of their baby, hence they are relying on convenient and safe baby care products. Technavio research shows that the changing lifestyles are a major factor triggering market growth, which has resulted in a projected CAGR of ov …
- 細胞培養タンパク質表面コーティングの世界市場分析：コーティング別（自己コーティング、プレコーティング[マルチウォール/マイクロウェルプレート、ペトリ皿、フラスコ、スライド、カバースリップ]）、タンパク質由来別（植物、動物、ヒト、合成）、セグメント予測、2014-2025The global cell culture protein surface coating market is expected to reach a value of USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing focus on stem cell research and development is the most substantial factor that drives the market growth during the forecast period. Stem cell therapy is the most promising method to treat severe medical conditions such as …
- MEK阻害剤の世界市場：メキニスト、コテリック、メクトビGlobal MEK Inhibitors Market 2019-2023: About the market MEK is a drug that inhibits the mitogen-activated extracellular signal-regulated kinase. Technavio’s MEK inhibitors market analysis considers sale from MEKINIST, COTELLIC, and MEKTOVI. Our analysis also considers the MEK inhibitors in Asia, Europe, North America, and ROW. In 2018, the MEKINIST segment had a significant share, and this trend …
- 偽造防止パッケージ技術の世界市場：認証技術、トレーサビリティー技術About Anti-counterfeit Packaging Anti-counterfeit packaging is the process of providing a secure packaging to products to reduce counterfeiting or imitation. The packaging not only helps companies to reduce losses incurred because of counterfeiting but also improves the safety of packaged goods. Governments in various countries are taking strong measures to stop counterfeiting by spreading awarene …
- 世界の高分子マトリックス複合材料市場2015The Global Polymer Matrix Composite Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Polymer Matrix Composite industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Polymer Matrix Composite market analysis is provided for the international markets inclu …
- Spanish Hospital Coagulation Testing Market 2014This new report from Venture Planning Group contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital coagulation testing market, including: Major issues pertaining to the Spanish coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. V …
- CEA：医療検査市場2014The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- 世界の白血病治療市場動向（2012-2016）TechNavio’s analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Leukemia Therapeutics market has also been witnessing an increase in the number of mergers and acquisitions. However, the delay in …
- Dominion Resources Black Warrior Trust：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Dominion Resources Black Warrior Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Dominion Resources Black Warrior Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. …
- 小型武器の世界市場About Small Arms There is no standard definition for small arms. However, in general the terms 'small arms' and 'light weapons' are used for weapons of this category. These are in general small and light weight weapon that can be operated by one person. They usually include revolvers, pistols, rifles, submachine guns, light machine guns, heavy machine guns, grenade launchers, portable anti-aircraf …
- エネルギー管理システム（EMS）の世界市場：デマンドレスポンス（DR）、IEMS、BEMS、HEMSAbout Energy Management System An energy management system (EMS) uses computer-aided tools to monitor, control, and optimize electrical loads. The EMS allows consumers to monitor and reduce the energy consumption of electrical and electronic devices and conserve energy. In this system, energy consumption can be easily monitored through cell phones, tablets, or other communication devices. It also …
